increased circulating thyroxine level_Dio2<tm1Vag>/Dio2<tm1Vag>

http://metadb.riken.jp/0005477I129S7SvEvBrdC57BL6Dio2tm1VagDio2tm1VagDio2tm1Vag

increased circulating thyroxine level_Dio2<tm1Vag>/Dio2<tm1Vag>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• deiodinase, iodothyronine, type II
  http://metadb.riken.jp/db/mgi_rdf/MGI:1338833

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Dio2<tm1Vag>/Dio2<tm1Vag>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Dio2<tm1Vag>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S7/SvEvBrd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased circulating thyroxine level
  http://purl.obolibrary.org/obo/MP_0005477

文献

http://purl.org/net/cito/citesAsAuthority

• M J. Schneider, et.al., Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4., Molecular endocrinology (Baltimore, Md.), 2001, 15
  http://rdf.ncbi.nlm.nih.gov/pubmed/11731615